Oncotype DX cost effectivity to a Brazilian public hospital

被引：0
|
作者：
Cabello, C. [1 ]
de Andrade, R. N. [1 ]
Cabello, T. F. [1 ]
Teixeira, S. [1 ]
da Costa, L. S. [1 ]
Ramalho, S. [1 ]
机构：
[1] State Univ Campinas UNICAMP, Campinas, SP, Brazil
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oncotype Dx: A Cost Effectiveness Analysis
    McHugh, F.
    Al Hilli, Z.
    Cassidy, T.
    O'Shea, A. M.
    Staunton, M.
    Hennessy, B.
    Patrick, M.
    Allen, M.
    Power, C.
    Hill, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S228 - S228
  • [2] Comparing Oncotype DX with Magee Equation 2: Analysis from an Urban Public Hospital
    Mullane, Patrick
    Mosunjac, Marina
    Birdsong, George
    Krishnamurti, Uma
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 222 - 223
  • [3] Comparing Oncotype DX with Magee Equation 2: Analysis from an Urban Public Hospital
    Mullane, Patrick
    Mosunjac, Marina
    Birdsong, George
    Krishnamurti, Uma
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 222 - 223
  • [4] Cost-Effectiveness of the Oncotype DX DCIS Score
    Raldow, A.
    Recht, A.
    Sher, D. J.
    Punglia, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S90 - S91
  • [5] Commentary on oncotype Dx
    Mehta, Prashant
    Batra, Atul
    Patel, Amol
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (03) : 434 - 434
  • [6] Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study
    Oliveira, Leandro Jonata Carvalho
    Megid, Thais Baccili Cury
    Rosa, Daniela Dornelles
    Magliano, Carlos Alberto da Silva
    Assad, Daniele Xavier
    Argolo, Daniel Fontes
    Sanches, Solange Moraes
    Testa, Laura
    Bines, Jose
    Kaliks, Rafael
    Caleffi, Maira
    de Melo Gagliato, Debora
    Sahade, Marina
    Barroso-Sousa, Romualdo
    Correa, Tatiana Strava
    Shimada, Andrea Kazumi
    Batista, Daniel Negrini
    Musse Gomes, Daniel
    Cesca, Marcelle Goldner
    Gaudencio, Debora
    Moura, Larissa Matos Almeida
    de Araujo, Julio Antonio Pereira
    Katz, Artur
    Mano, Max Senna
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [7] COST-EFFECTIVENESS OF THE ONCOTYPE DX® ASSAY IN AUSTRALIA: AN EXPLORATORY ANALYSIS
    O'Leary, B.
    Foteff, C.
    Byron, K.
    Chang, C.
    Chao, C.
    Ng, C.
    Skrzypczak, S.
    VALUE IN HEALTH, 2010, 13 (07) : A512 - A512
  • [8] ONCOTYPE DX® - THE SiRIO-LIBANeS HOSPITAL CANCER CENTER EXPERIENCE
    Pereira, A. A. L.
    Shimada, A. K.
    Santini, F. C.
    Nascimento, E. C.
    Ribeiro, K. B.
    Marques, R. J.
    Mano, M. S.
    Katz, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 112 - 112
  • [9] Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: A GBECAM multicenter retrospective study.
    Oliveira, Leandro Carvalho
    Cury Megid, Thais Baccili
    Rosa, Daniela Dornelles
    da Silva Magliano, Carlos Alberto
    Suzuki, Daniele Assad
    Argolo, Daniel F.
    Sanches, Solange Moraes
    Testa, Laura
    Bines, Jose
    Kaliks, Rafael Alioska
    Caleffi, Maira
    Gagliato, Debora De Melo
    Sahade, Marina
    Barroso-Sousa, Romualdo
    Correa, Tatiana Strava
    Shimada, Andrea
    Katz, Artur
    Mano, Max S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18822 - E18822
  • [10] Independent Validation of Oncotype DX™
    Davey, M.
    Elwahabi, S. A.
    Elliott, J. A.
    McAnena, P.
    O'Donnell, J.
    Barry, K.
    Malone, C.
    Sweeney, K.
    McLaughlin, R.
    Lowery, A.
    Kerin, M.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 17 - 17
12345